#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    HER2 mutant non-small cell lung cancer Wolfram syndrome Desmoplastic small round cell tumour Von Hippel-Lindau disease Chronic kidney disease Neuropathic arthropathy Neuroendocrine carcinoma Hepatoblastoma Osteomyelitis Pelizaeus-Merzbacher disease Short-bowel syndrome B-cell lymphoma recurrent Mucous membrane pemphigoid Glomerulonephritis acute Acute graft versus host disease More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Basic Information Angiosarcoma metastatic – Diagnostics Mucopolysaccharidosis – Basic Information Hereditary angioedema Ewing’s sarcoma – Trials in Disease Niemann-Pick disease – Diagnostics Atypical haemolytic uraemic syndrome – Basic Information Hairy cell leukaemia recurrent – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Rett syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Doxycycline Monohydrate Ceftazidime Pentahydrate Warfarin MAGNESIUM CARBONATE HEAVY MRNA-1345 Inotuzumab Ozogamicin Tenofovir Alafenamide Amantadine Hemisulfate Ttx-030 ZODASIRAN Deflazacort Doxycycline Ecopipam Hydrochloride Padeliporfin 68Ga-Nota-Abscint-Her2 Pantothenate Sodium Bupivacaine Hydrochloride Gallium (68Ga) Gozetotide Vigabatrin IADADEMSTAT More therapies…

    Learn about Your Condition

    Vasospasm Spinal cord injury Neurofibromatosis Choroidal dystrophy Metastatic malignant melanoma Glucose tolerance impaired Aortic stenosis Fragile X syndrome Hereditary ataxia Brain stem glioma Tissue anoxia Atrial fibrillation Retroperitoneal cancer Naevus flammeus Coronary artery disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lung transplant

  • Study on the Safety of Allogeneic Mesenchymal Stromal Cells for Patients with Chronic Lung Transplant Rejection

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung transplant
    • Lung transplant rejection
    Investigated Drugs:
    • Allogeneic Bone Marrow-Derived Mesenchymal Adult Stromal Cells, Ex-Vivo Expanded
    Spain

  • Immunogenicity and safety of RSV A/B prefusion F protein vaccine versus RSV F glycoprotein recombinant adjuvanted vaccine in lung and stem cell transplant recipients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung transplant
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    France

  • Study on Heart-Lung Support Without Heparin for Patients Undergoing Lung Transplantation Using Sodium Chloride and Placebo

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung transplant
    Investigated Drugs:
    • Heparin Sodium
    • Sodium Chloride
    Austria

  • Study Comparing Immediate and Extended Release Tacrolimus to Reduce Toxicity in Lung Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung transplant
    Investigated Drugs:
    • Tacrolimus
    The Netherlands

  • Study on Letermovir for Preventing CMV Infection in Lung Transplant Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung transplant
    • Cytomegalovirus infection
    Investigated Drugs:
    • Letermovir
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!